-
Published31/03/2025
-
Deadline29/04/2025
-
Opening of tenders29/04/2025
-
Today30/04/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Delivery of Dupilumab as part of Therapeutic Medicines Programmes Text automatically translated in your browsing language Automatically translated
The subject of the order is the successive delivery of Duilumab as part of the Therapeutic Drug Programs used in the treatment of atopic skin treatment (AS) in children. Detailed parameters in the scope of the subject of the contract (description of the subject of the contract, estimated quantities) are set out in Annex 2 to the SWZ. Text automatically translated in your browsing language Automatically translated
https://platformazakupowa.pl/transakcja/1084582
https://platformazakupowa.pl/transakcja/1084582
33600000 - Pharmaceutical products
33100000 - Medical equipments CVP code deduced from the text of the procedure AI-generated
Type: price
Description: Przy wyborze najkorzystniejszej oferty Zamawiający będzie kierował się kryterium 100% cena. Opis kryteriów oceny ofert wskazano w Rozdziale XXIV SWZ.
Weight (percentage, exact): 100
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.